Skip to main content
. 2017 Feb 8;30(2):481–502. doi: 10.1128/CMR.00090-16

TABLE 1.

Chemokines, cytokines, and other immune molecules involved in the human immune response to RSV infectiona

Immune molecule(s) Productionb
Comments Reference(s)d
Respiratory tractc
Systemic
Nasal mucosa Lung
Th1 cytokines
    IFN-γ + + + Protective
    IL-12 + + + Protective
    IL-1α and IL-1β + + Deleterious
    IL-2 + + + No reported association with severity
    TNF-α + + + Deleterious
    IL-18 + Protective
    sCD25 + Deleterious
Th2 cytokines
    IL-4 + + + Deleterious
    IL-6 + + + Variable association with severity (see text)
    IL-9 + + No reported association with severity
    IL-10 + + + Variable association with severity (see text)
    IL-13 + + + No reported association with severity
Other cytokines
    IL-8 + + + Deleterious: neutrophil chemoattractant
    IL-17A + + Variable association with severity (see text)
    IL-33 + No reported association with severity 130
Chemokines
    CCL-2 (MCP-1) + + Deleterious
    CCL-3 (MIP-1α) + + Deleterious
    CCL-4 (MIP-1β) + Variable association with severity (see text)
    CCL-5 (RANTES) + + Protective
    CXCL-10 (IP-10) + + Deleterious
    Eotaxin + + Deleterious
Other
    IFN-λ + Deleterious despite stimulating ISG expression 159, 160
    IFN-α + + No reported association with severity 158
    G-CSF + + Circulating levels are higher in infants with RSV LRTI requiring ventilation 18, 105
    Soluble ICAM-1 + + Levels in nasal fluid positively correlate with severity 40, 124, 126
    Substance P + + Lower concentrations associated with increased severity 106
    MBL No reported association with severity 44
    Cathelicidin LL-37 + Protective: in human exptl infection, higher constitutive nasal levels are associated with reduced development of infection 177
    Olfactomedin 4 + Greater expression in PBMC was associated with need for ventilation in RSV LRTI 19
    Surfactants A, B, D + The pulmonary level of surfactant A and measurable surfactant activity increase during recovery 178181
    MMP-9, MMP-3, PGP + Elevated pulmonary levels in ventilated infants are associated with hypoxia and acute lung injury 182184
    KL-6 + Circulating levels are greater in infants with RSV LRTI requiring ventilation 185
    sTRAIL + No reported association with severity 186
a

Abbreviations: CCL, C-C motif chemokine ligand; CXCL, C-X-C motif chemokine ligand; G-CSF, granulocyte colony-stimulating factor; ICAM, intercellular adhesion molecule; IFN, interferon; IL, interleukin; IP-10, IFN-γ-inducible protein-10; ISG, interferon-stimulated gene; MBL, mannose binding lectin; MCP-1, monocyte chemoattractant protein-1; MIP, macrophage inflammatory protein; MMP, matrix metalloproteinase; PGP, proline-glycine-proline (the product of MMP hydrolysis of collagen); RANTES, regulated on activation, normal T expressed and secreted; sTRAIL, soluble TNF-related apoptosis-inducing ligand; TIMP, tissue inhibitor of metalloproteinase; TNF, tumor necrosis factor.

b

+, increased production; −, reduced production.

c

Nasal mucosa, measurements made in nasal fluid or nasopharyngeal aspirate; lung, measurements made in bronchoalveolar lavage fluid or tracheal aspirate.

d

References are provided for molecules not discussed in detail in the text.